I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Karsa, Mawar
38
results:
Search for persons
X
Format
Online (38)
Mediatypes
Articles (Online) (13)
OpenAccess-fulltext (25)
Sorted by: Relevance
Sorted by: Year
?
1
FDA-approved disulfiram as a novel treatment for aggressive..:
Karsa, Mawar
;
Xiao, Lin
;
Ronca, Emma
...
Journal of Molecular Medicine. 102 (2024) 4 - p. 507-519 , 2024
Link:
https://doi.org/10.1007/..
?
2
Direct targeted therapy for MLL‐fusion‐driven high‐risk acu..:
Cantilena, Sandra
;
Gasparoli, Luca
;
Pal, Deepali
...
Clinical and Translational Medicine. 12 (2022) 6 - p. , 2022
Link:
https://doi.org/10.1002/..
?
3
The Combination of Curaxin CBL0137 and Histone Deacetylase ..:
Xiao, Lin
;
Karsa, Mawar
;
Ronca, Emma
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
4
Systematic In Vitro Evaluation of a Library of Approved and..:
Karsa, Mawar
;
Ronca, Emma
;
Bongers, Angelika
...
Frontiers in Oncology. 11 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
5
Exploiting the reactive oxygen species imbalance in high-ri..:
Karsa, Mawar
;
Kosciolek, Angelika
;
Bongers, Angelika
...
British Journal of Cancer. 125 (2021) 1 - p. 55-64 , 2021
Link:
https://doi.org/10.1038/..
?
6
A novel small molecule that kills a subset of MLL-rearrange..:
Somers, Klaartje
;
Wen, Victoria W.
;
Middlemiss, Shiloh M. C.
...
Oncogene. 38 (2019) 20 - p. 3824-3842 , 2019
Link:
https://doi.org/10.1038/..
?
7
Effective targeting of NAMPT in patient-derived xenograft m..:
Somers, Klaartje
;
Evans, Kathryn
;
Cheung, Leanna
...
Leukemia. 34 (2019) 6 - p. 1524-1539 , 2019
Link:
https://doi.org/10.1038/..
?
8
Potent antileukemic activity of curaxin CBL0137 against MLL..:
Somers, Klaartje
;
Kosciolek, Angelika
;
Bongers, Angelika
...
International Journal of Cancer. 146 (2019) 7 - p. 1902-1916 , 2019
Link:
https://doi.org/10.1002/..
?
9
CCI-007, a novel small molecule with cytotoxic activity aga..:
Somers, Klaartje
;
Chudakova, Daria A.
;
Middlemiss, Shiloh M.C.
...
Oncotarget. 7 (2016) 29 - p. 46067-46087 , 2016
Link:
https://doi.org/10.18632..
?
10
Whole-genome sequencing analysis of phenotypic heterogeneit..:
Ariffin, Hany
;
Hainaut, Pierre
;
Puzio-Kuter, Anna
...
Proceedings of the National Academy of Sciences. 111 (2014) 43 - p. 15497-15501 , 2014
Link:
https://doi.org/10.1073/..
?
11
Whole-genome sequencing analysis of phenotypic heterogeneit..:
Ariffin, Hany
;
Hainaut, Pierre
;
Puzio-Kuter, Anna
...
Proceedings of the National Academy of Sciences of the United States of America. 111 (2014) 43 - p. 15497-15501 , 2014
Link:
https://www.jstor.org/st..
?
12
Reliable genotyping of the koala (Phascolarctos cinereus) u..:
Wedrowicz, Faye
;
Karsa, Mawar
;
Mosse, Jennifer
.
Molecular Ecology Resources. 13 (2013) 4 - p. 634-641 , 2013
Link:
https://doi.org/10.1111/..
?
13
Improving the Identification of High Risk Precursor B Acute..:
Karsa, Mawar
;
Dalla Pozza, Luciano
;
Venn, Nicola C.
...
PLoS ONE. 8 (2013) 10 - p. e76455 , 2013
Link:
https://doi.org/10.1371/..
?
14
Direct targeted therapy for MLL-fusion-driven high-risk acu..:
Cantilena, Sandra
;
Gasparoli, Luca
;
Pal, Deepali
...
https://www.repository.cam.ac.uk/handle/1810/339424. , 2022
Link:
https://www.repository.c..
?
15
Direct targeted therapy for MLL-fusion-driven high-risk acu..:
Cantilena, Sandra
;
Gasparoli, Luca
;
Pal, Deepali
...
https://www.repository.cam.ac.uk/handle/1810/337999. , 2022
Link:
https://www.repository.c..
1-15